Cite
HARVARD Citation
Bourdin, A. et al. (2021). Dupilumab is effective in type 2‐high asthma patients receiving high‐dose inhaled corticosteroids at baseline. Allergy. 76 (1), pp. 269-280. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bourdin, A. et al. (2021). Dupilumab is effective in type 2‐high asthma patients receiving high‐dose inhaled corticosteroids at baseline. Allergy. 76 (1), pp. 269-280. [Online].